Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING INDUSTRY
2.1 Summary about Viral Vector & Plasmid DNA Manufacturing Industry
2.2 Viral Vector & Plasmid DNA Manufacturing Market Trends
2.2.1 Viral Vector & Plasmid DNA Manufacturing Production & Consumption Trends
2.2.2 Viral Vector & Plasmid DNA Manufacturing Demand Structure Trends
2.3 Viral Vector & Plasmid DNA Manufacturing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Adenovirus
4.2.2 Retrovirus
4.2.3 Plasmid DNA
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Biopharmaceutical Companies
4.3.2 Research Institutes
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Adenovirus
5.2.2 Retrovirus
5.2.3 Plasmid DNA
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Biopharmaceutical Companies
5.3.2 Research Institutes
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Adenovirus
6.2.2 Retrovirus
6.2.3 Plasmid DNA
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Biopharmaceutical Companies
6.3.2 Research Institutes
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Adenovirus
7.2.2 Retrovirus
7.2.3 Plasmid DNA
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Biopharmaceutical Companies
7.3.2 Research Institutes
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Adenovirus
8.2.2 Retrovirus
8.2.3 Plasmid DNA
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Biopharmaceutical Companies
8.3.2 Research Institutes
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Adenovirus
9.2.2 Retrovirus
9.2.3 Plasmid DNA
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Biopharmaceutical Companies
9.3.2 Research Institutes
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 uniQure
10.1.3 The Cell and Gene Therapy Catapult
10.1.4 Waisman Biomanufacturing
10.1.5 Addgene
10.1.6 Creative Biogene
10.1.7 Novasep
10.1.8 Cobra Biologics
10.1.9 Aldevron
10.2 Viral Vector & Plasmid DNA Manufacturing Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 uniQure
10.2.3 The Cell and Gene Therapy Catapult
10.2.4 Waisman Biomanufacturing
10.2.5 Addgene
10.2.6 Creative Biogene
10.2.7 Novasep
10.2.8 Cobra Biologics
10.2.9 Aldevron
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.